We cannot rule out the possibility that these tracers might exhibit different binding affinity depending on the maturity of the tau lesions, as it has been suggested by others [25], since all AD cases included in the present study, except for one, were at high Braak tangle stages (IV-VI) (Table 1). This evidence concerns the gene MAPT and Alzheimer disease.